Abstract:Background: Duchenne muscular dystrophy (DMD) is caused by loss of sarcolemma connection to the extracellular matrix. Transgenic overexpression of the transmembrane protein sarcospan (SSPN) in the DMD mdx mouse model significantly reduces disease pathology by restoring membrane adhesion. Identifying SSPN-based therapies has the potential to benefit patients with DMD and other forms of muscular dystrophies caused by deficits in muscle cell adhesion. Methods: Standard cloning methods were used to generate C2C12 myoblasts stably transfected with a fluorescence reporter for human SSPN promoter activity. Assay development and screening were performed in a core facility using liquid handlers and imaging systems specialized for use with a 384-well microplate format. Drug-treated cells were analyzed for target gene expression using quantitative PCR and target protein expression using immunoblotting. Results: We investigated the gene expression profiles of SSPN and its associated proteins during myoblast differentiation into myotubes, revealing an increase in expression after 3 days of differentiation. We created C2C12 muscle cells expressing an EGFP reporter for SSPN promoter activity and observed a comparable increase in reporter levels during differentiation. Assay conditions for high-throughput screening were optimized for a 384-well microplate format and a high-content imager for the visualization of reporter levels. We conducted a screen of 3200 compounds and identified seven hits, which include an overrepresentation of L-type calcium channel antagonists, suggesting that SSPN gene activity is sensitive to calcium. Further validation of a select hit revealed that the calcium channel inhibitor felodipine increased SSPN transcript and protein levels in both wild-type and dystrophin-deficient myotubes, without increasing differentiation. Conclusions: We developed a stable muscle cell line containing the promoter region of the human SSPN protein fused to a fluorescent reporter. Using the reporter cells, we created and validated a scalable, cell-based assay that is able to identify compounds that increase SSPN promoter reporter, transcript, and protein levels in wild-type and dystrophin-deficient muscle cells.

A Method for Screening Utrophin Expression Activators from Traditional Chinese Medicine Library

Construction of a Cellular Model for Drug Screening of Duchenne Muscular Dystrophy.

Ononin, Sec-O-β-d-glucosylhamaudol and Astragaloside I: Antiviral Lead Compounds Identified Via High Throughput Screening and Biological Validation from Traditional Chinese Medicine Zhongjing Formulary.

A Dual-Fluorescent Whole-Well Imaging Approach For Screening Active Compounds Against Doxorubicin-Induced Cardiotoxicity From Natural Products

Development of a rapid screening method for discovering neuroprotective components from traditional Chinese medicine]

Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy

A System for Screening Agonists Targeting Β2-Adrenoceptor from Chinese Medicinal Herbs

Identification of Upregulators of BMP2 Expression Via High-Throughput Screening of a Synthetic and Natural Compound Library

High-content screening of active components of Traditional Chinese Medicine inhibiting TGF-?-induced cell EMT

Identification of hub genes and therapeutic siRNAs to develop novel adjunctive therapy for Duchenne muscular dystrophy

Comprehensive Bioinformatics Analysis Combined with Wet-Lab Experiments to Find Target Proteins of Chinese Medicine Monomer

Rapid screening and identification of superoxide dismutase activators from traditional Chinese medicines based on affinity ultrafiltration mass chromatography combined with molecular docking

A novel functional assessment of the differentiation of micropatterned muscle cells.

Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models

Discovery of Quinazoline and Quinoline-Based Small Molecules as Utrophin Upregulators via AhR Antagonism for the Treatment of Duchenne Muscular Dystrophy

Combined screening of multiplex polymerase chain reaction and denaturing high-performance liquid chromatography in Duchenne muscular dystrophy with mutation deletion

Screening Potential Mitochondria-Targeting Compounds from Traditional Chinese Medicines Using a Mitochondria-Based Centrifugal Ultrafiltration/liquid Chromatography/mass Spectrometry Method

Identification and Evaluation of Traditional Chinese Medicine Natural Compounds as Potential Myostatin Inhibitors: An In Silico Approach

Screening of Duchenne Muscular Dystrophy (DMD) Mutations and Investigating Its Mutational Mechanism in Chinese Patients.

Screening the Active Constituents of Chinese Medicinal Herbs As Potent Inhibitors of Cdc25 Tyrosine Phosphatase, an Activator of the Mitosis-Inducing P34cdc2 Kinase

Comparative Normal/Failing Rat Myocardium Cell Membrane Chromatographic Analysis System for Screening Specific Components That Counteract Doxorubicin-Induced Heart Failure from Acontium carmichaeli